Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine) (Q73200055)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11082479%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11082479%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

R D Shytle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11082479%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A A Silver

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11082479%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P R Sanberg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11082479%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11082479%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11082479%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11082479%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11082479%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1028-1031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11082479%20AND%20SRC:MED&resulttype=core&format=json

Bipolar disorder in adult patients with Tourette's syndrome: a clinical study

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

Accumbal dopamine overflow after ethanol: localization of the antagonizing effect of mecamylamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

Gilles de la Tourette's syndrome and bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

Tourette disorder and bipolar symptomatology in childhood and adolescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

Comorbid Tourette's disorder and bipolar disorder: an etiologic perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

What is the nature of mecamylamine's antagonism of the central effects of nicotine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

Treatment of Tourette's syndrome with mecamylamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

The effect of comorbid substance use disorders on the course of bipolar disorder: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

Up-regulation of sodium channel subunit mRNAs and their cell surface expression by antiepileptic valproic acid: activation of calcium channel and catecholamine secretion in adrenal chromaffin cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900945-8

10.1016/S0006-3223(00)00945-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11082479%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference